Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication

Rak Kyun Seong, Seong wook Seo, Ji Ae Kim, Sarah J. Fletcher, Neil V. Morgan, Mukesh Kumar, Young Ki Choi, Ok Sarah Shin

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)


Schlafen (SLFN) proteins have been suggested to play important functions in cell proliferation and immune cell development. In this study, we determined the antiviral activities of putative RNA-helicase domain-containing SLFN14. Murine SLFN14 expression was specifically induced by TLR3-mediated pathways and type I interferon (IFN) in RAW264.7 mouse macrophages. To examine the role of SLFN during viral infection, cells were infected with either wild-type PR8 or delNS1/PR8 virus. SLFN14 expression was specifically induced following influenza virus infection. Overexpression of SLFN14 in A549 cells reduced viral replication, whereas knockdown of SLFN14 in RAW264.7 cells enhanced viral titers. Furthermore, SLFN14 promoted the delay in viral NP translocation from cytoplasm to nucleus and enhanced RIG-I-mediated IFN-β signaling. In addition, SLFN14 overexpression promoted antiviral activity against varicella zoster virus (VZV), a DNA virus. In conclusion, our data suggest that SLFN14 is a novel antiviral factor for both DNA and RNA viruses.

Original languageEnglish
Pages (from-to)979-988
Number of pages10
Issue number11
Publication statusPublished - 2017 Nov

Bibliographical note

Publisher Copyright:
© 2017 Elsevier GmbH


  • Anti-viral
  • Influenza
  • Interferon
  • SLFN14
  • VZV

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology


Dive into the research topics of 'Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication'. Together they form a unique fingerprint.

Cite this